ArticleInternational journal of oncology2018

CRISPR/Cas9-mediated ASXL1 mutations in U937 cells disrupt myeloid differentiation.

Zhi-Jie Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.